MyAverix Finance
SHE · Healthcare
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096)
Drug Manufacturers - General
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-28, reported market cap is $5.69B, P/E ratio is 18.00, net margin is -31.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301096
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) — FAQ
What is Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.'s market cap?
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a reported market cap of $5.69B (data as of 2026-03-28).
What is 301096's P/E ratio?
The price-to-earnings (P/E) ratio for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) is 18.00 (data as of 2026-03-28).
Does Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096). Check the MyAverix Finance app for the latest dividend data.
What sector is Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. in?
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is 301096 listed on?
301096 is listed on SHE.
What is Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.'s net margin?
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) reports a net margin of -31.9% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.